July 15, 2026 · Form 4 insider transaction
Sundaram Preethi sold 54,804 shares of Catalyst Pharmaceuticals Inc at $31.50 per share, a transaction worth $1.73M. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 2 days after the transaction.
The reported securities were disposed of in connection with the consummation of the acquisition of the Issuer by Angelini Pharma S.p.A. (the "Merger")